Findings

CVE-2025-36226

IBM Aspera Faspex 5 5.0.0 through 5.0.14.3 is vulnerable to cross-site scripting.

Published Mar 10, 2026 · updated Jun 17, 2026 · ibm aspera faspex

IBM Aspera Faspex 5 5.0.0 through 5.0.14.3 is vulnerable to cross-site scripting. This vulnerability allows an authenticated user to embed arbitrary JavaScript code in the Web UI thus altering the intended functionality potentially leading to credentials disclosure within a trusted session.

Code

The project this record applies to. Exploit listings stay in References.

No public source repository is identified for this product.

Timeline

Detection, updates, and resolution for this record.

  1. Mar 10, 2026 · NIST NVD

    Detected

    IBM Aspera Faspex 5 5.0.0 through 5.0.14.3 is vulnerable to cross-site scripting. This vulnerability allows an authenticated user to embed arbitrary JavaScript code in the Web UI thus altering the intended functionality potentially leading to credentials disclosure within a trusted session.

  2. Jun 17, 2026 · NIST NVD

    Updated

    IBM Aspera Faspex 5 5.0.0 through 5.0.14.3 is vulnerable to cross-site scripting. This vulnerability allows an authenticated user to embed arbitrary JavaScript code in the Web UI thus altering the intended functionality potentially leading to credentials disclosure within a trusted session.

Affected

  • cpe ibm/aspera faspexversion unspecified

Sources

  • CVE.orgVulnerability recordCVE-2025-36226

    Official CVE identifier

    cve.org
  • NIST NVDVulnerability recordCVE-2025-36226

    IBM Aspera Faspex 5 5.0.0 through 5.0.14.3 is vulnerable to cross-site scripting. This vulnerability allows an authenticated user to embed arbitrary JavaScript code in the Web UI thus altering the intended functionality potentially leading to credentials disclosure within a trust

    nvd.nist.gov

References